This year’s panel sees the return of 10 thought leaders with the addition of three new members, covering the entire pharmaceutical supply chain from R&D through to finished products, regulatory requirements and economic implications. Additionally, this year panel members are utilising their market insights and analysis year round in the CPhI Pharma Insights series, which cover individual topics and developments across the industry- including the released R&D, manufacturing and Turkey reports, with a United States report due out imminently.
Monday, 21 July 2014
CPhI panel to analyse new industry
This year’s panel sees the return of 10 thought leaders with the addition of three new members, covering the entire pharmaceutical supply chain from R&D through to finished products, regulatory requirements and economic implications. Additionally, this year panel members are utilising their market insights and analysis year round in the CPhI Pharma Insights series, which cover individual topics and developments across the industry- including the released R&D, manufacturing and Turkey reports, with a United States report due out imminently.
Labels:
CPhI,
pharmaceutical,
R&D,
supply chain,
Worldwide
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment